Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer

NCT04113005 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Castrate Resistance Prostate Cancer

Interventions

DRUG: Desmopressin

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]